Victory Capital Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,519,327
Closed -$18.9M 2645
2022
Q4
$18.9M Buy
1,519,327
+161,429
+12% +$2.35M 0.02% 792
2022
Q3
$18.5M Buy
1,357,898
+591,580
+77% +$9.12M 0.02% 846
2022
Q2
$14M Buy
+766,318
New +$11M 0.02% 949
2021
Q3
Sell
-70,540
Closed -$1.47M 2812
2021
Q2
$1.47M Sell
70,540
-1,601,034
-96% -$39.7M ﹤0.01% 1732
2021
Q1
$47.3M Buy
1,671,574
+141,324
+9% +$4.47M 0.05% 570
2020
Q4
$50M Sell
1,530,250
-173,429
-10% -$6.09M 0.06% 524
2020
Q3
$52.2M Sell
1,703,679
-327,471
-16% -$7.23M 0.07% 450
2020
Q2
$33.1M Sell
2,031,150
-581,669
-22% -$8.39M 0.04% 573
2020
Q1
$26M Buy
2,612,819
+238,233
+10% +$2.73M 0.04% 553
2019
Q4
$32.7M Buy
2,374,586
+107,970
+5% +$1.6M 0.04% 643
2019
Q3
$34.4M Buy
2,266,616
+299,346
+15% +$5.33M 0.04% 590
2019
Q2
$38.7M Buy
1,967,270
+210,900
+12% +$3.5M 0.08% 391
2019
Q1
$29.1M Buy
1,756,370
+64,150
+4% +$988K 0.07% 457
2018
Q4
$23.8M Buy
1,692,220
+155,910
+10% +$2.07M 0.06% 497
2018
Q3
$26.9M Buy
1,536,310
+47,070
+3% +$902K 0.06% 532
2018
Q2
$27.1M Buy
+1,489,240
New +$25.2M 0.06% 517

Other funds holding KURA

Victory Capital Management's KURA Position: Q1 2023 in Review

Victory Capital Management sold out of Kura Oncology (KURA) in Q1 2023, closing a stake of 1,519,327 shares — an estimated $18.9M sold.

Victory Capital Management first reported a position in KURA in Q2 2018 and held it in 16 quarters. The position peaked at $52.2M in Q3 2020. 141 funds tracked by Wall St. Rank hold KURA as of Q1 2023.

  • Victory Capital Management reported no remaining Kura Oncology position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 1,519,327 Kura Oncology shares in Q1 2023, an estimated $18.9M.
  • Victory Capital Management first reported a position in Kura Oncology in Q2 2018 and held it in 16 quarters.
  • Victory Capital Management's Kura Oncology position peaked at $52.2M in Q3 2020.
  • 141 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.